Company · CIK 0001108205 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
CURIS INC · CRIS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 AForm 4 → | Jul 9, 4:12 pm EDT | Marc RubinDirector | 6,800 | $5.29 | $35,972 | 6,800 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:12 pm EDT | Kenneth I KaitinDirector | 6,800 | $5.29 | $35,972 | 6,800 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:12 pm EDT | John HohnekerDirector | 6,800 | $5.29 | $35,972 | 6,800 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:11 pm EDT | Martyn D GreenacreDirector | 6,800 | $5.29 | $35,972 | 6,800 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:11 pm EDT | Anne Elizabeth BorgmanDirector | 6,800 | $5.29 | $35,972 | 6,800 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:11 pm EDT | Diantha DuvallCFO | 48,285 | $5.29 | $255,428 | 48,285 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:09 pm EDT | Jonathan B. ZungCDO | 48,285 | $5.29 | $255,428 | 48,285 | — | |
| Jul 7, 2026 AForm 4 → | Jul 9, 4:09 pm EDT | James E DentzerPresident & CEO, Director | 110,090 | $5.29 | $582,376 | 110,090 | — |